Suppr超能文献

超越优先选项:利用既往药物耐受性证据抑制药物过敏警报;一项关于阿片类药物警报的回顾性研究

Beyond the override: Using evidence of previous drug tolerance to suppress drug allergy alerts; a retrospective study of opioid alerts.

作者信息

Colicchio Tiago K, Cimino James J

机构信息

Informatics Institute, University of Alabama at Birmingham, AL, USA.

Informatics Institute, University of Alabama at Birmingham, AL, USA.

出版信息

J Biomed Inform. 2023 Nov;147:104508. doi: 10.1016/j.jbi.2023.104508. Epub 2023 Sep 23.

Abstract

OBJECTIVE

Despite the extensive literature exploring alert fatigue, most studies have focused on describing the phenomenon, but not on fixing it. The authors aimed to identify data useful to avert clinically irrelevant alerts to inform future research on clinical decision support (CDS) design.

METHODS

We conducted a retrospective observational study of opioid drug allergy alert (DAA) overrides for the calendar year of 2019 at a large academic medical center, to identify data elements useful to find irrelevant alerts to be averted.

RESULTS

Overall, 227,815 DAAs were fired in 2019, with an override rate of 91 % (n = 208196). Opioids represented nearly two-thirds of these overrides (n = 129063; 62 %) and were the drug class with the highest override rate (96 %). On average, 29 opioid DAAs were overridden per patient. While most opioid alerts (97.1 %) are fired for a possible match (the drug class of the allergen matches the drug class of the prescribed drug), they are overridden significantly less frequently for definite match (exact match between allergen and prescribed drug) (88 % vs. 95.9 %, p < 0.001). When comparing the triggering drug with previously administered drugs, override rates were equally high for both definite match (95.9 %), no match (95.5 %), and possible match (95.1 %). Likewise, when comparing to home medications, overrides were excessively high for possible match (96.3 %), no match (96 %), and definite match (94.4 %).

CONCLUSION

We estimate that 74.5% of opioid DAAs (46.4% of all DAAs) at our institution could be relatively safely averted, since they either have a definite match for previous inpatient administrations suggesting drug tolerance or are fired as possible match with low risk of cross-sensitivity. Future research should focus on identifying other relevant data elements ideally with automated methods and use of emerging standards to empower CDS systems to suppress false-positive alerts while avoiding safety hazards.

摘要

目的

尽管有大量文献探讨警报疲劳问题,但大多数研究都集中在描述这一现象,而非解决该问题。作者旨在识别有助于避免临床无关警报的数据,为未来临床决策支持(CDS)设计的研究提供信息。

方法

我们对一家大型学术医疗中心2019年全年的阿片类药物过敏警报(DAA)覆盖情况进行了回顾性观察研究,以确定有助于找出可避免的无关警报的数据元素。

结果

2019年共触发227,815次DAA,覆盖率为91%(n = 208196)。阿片类药物占这些覆盖情况的近三分之二(n = 129063;62%),是覆盖率最高的药物类别(96%)。平均每位患者有29次阿片类DAA被覆盖。虽然大多数阿片类警报(97.1%)是因可能匹配(过敏原的药物类别与处方药的药物类别匹配)而触发,但对于确定匹配(过敏原与处方药完全匹配),其被覆盖的频率显著较低(88%对95.9%,p < 0.001)。将触发药物与先前使用的药物进行比较时,确定匹配(95.9%)、不匹配(95.5%)和可能匹配(95.1%)的覆盖率同样高。同样,与家庭用药相比,可能匹配(96.3%)、不匹配(96%)和确定匹配(94.4%)的覆盖率过高。

结论

我们估计,我们机构74.5%的阿片类DAA(占所有DAA的46.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验